Literature DB >> 15108293

Detection of Parkin (PARK2) and DJ1 (PARK7) mutations in early-onset Parkinson disease: Parkin mutation frequency depends on ethnic origin of patients.

Ana Djarmati1, Katja Hedrich, Marina Svetel, Nora Schäfer, Vladislava Juric, Slobodanka Vukosavic, Robert Hering, Olaf Riess, Stanka Romac, Christine Klein, Vladimir Kostic.   

Abstract

Mutations in the Parkin (PARK2) and the DJ1 (PARK7) gene cause early-onset Parkinson disease (EOPD). We tested 75 Serbian EOPD patients for mutations in both genes by conventional mutational screening (SSCP/dHPLC/sequencing) to detect small sequence alterations and by gene dosage studies (quantitative PCR) to reveal deletions or multiplications of one or more exons. A compound heterozygous Parkin mutation (exon deletion and point mutation; [c.836_972del]+[c.1411C>T]; +1 is first nucleotide of GenBank AB009973.1) was identified in a patient who showed a relatively benign course after a disease onset at 41 years. Another case had a heterozygous exon deletion in DJ1 ([c.253_322del]+[?]) and presented with an age at onset of 45 years and a rapid disease course. In conclusion, Parkin mutations are surprisingly rare in our Serbian EOPD sample, suggesting that the mutation rate depends on the ethnic origin of the patients. Although DJ1 mutations appear to be rare, we confirm their role in EOPD and demonstrate the importance of gene dosage studies. Copyright 2004 Wiley-Liss, Inc.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 15108293     DOI: 10.1002/humu.9240

Source DB:  PubMed          Journal:  Hum Mutat        ISSN: 1059-7794            Impact factor:   4.878


  19 in total

Review 1.  Genetic predispositions of Parkinson's disease revealed in patient-derived brain cells.

Authors:  Jenne Tran; Helena Anastacio; Cedric Bardy
Journal:  NPJ Parkinsons Dis       Date:  2020-04-24

2.  PARK2 variability in Polish Parkinson's disease patients--interaction with mitochondrial haplogroups.

Authors:  Katarzyna Gaweda-Walerych; Krzysztof Safranow; Barbara Jasinska-Myga; Monika Bialecka; Gabriela Klodowska-Duda; Monika Rudzinska; Krzysztof Czyzewski; Stephanie A Cobb; Jaroslaw Slawek; Maria Styczynska; Grzegorz Opala; Marek Drozdzik; Kenya Nishioka; Matthew J Farrer; Owen A Ross; Zbigniew K Wszolek; Maria Barcikowska; Cezary Zekanowski
Journal:  Parkinsonism Relat Disord       Date:  2012-02-22       Impact factor: 4.891

Review 3.  Synaptic protein alterations in Parkinson's disease.

Authors:  Ilse S Pienaar; David Burn; Christopher Morris; David Dexter
Journal:  Mol Neurobiol       Date:  2011-12-29       Impact factor: 5.590

Review 4.  Neural stem cells in Parkinson's disease: a role for neurogenesis defects in onset and progression.

Authors:  Jaclyn Nicole Le Grand; Laura Gonzalez-Cano; Maria Angeliki Pavlou; Jens C Schwamborn
Journal:  Cell Mol Life Sci       Date:  2014-11-18       Impact factor: 9.261

5.  Mutations in DJ-1 are rare in familial Parkinson disease.

Authors:  Nathan Pankratz; Michael W Pauciulo; Veronika E Elsaesser; Diane K Marek; Cheryl A Halter; Joanne Wojcieszek; Alice Rudolph; Clifford W Shults; Tatiana Foroud; William C Nichols
Journal:  Neurosci Lett       Date:  2006-09-25       Impact factor: 3.046

6.  Effective quantitative real-time polymerase chain reaction analysis of the parkin gene (PARK2) exon 1-12 dosage.

Authors:  Maria I Shadrina; Elena V Semenova; Petr A Slominsky; Gulbahar H Bagyeva; Sergei N Illarioshkin; Irina I Ivanova-Smolenskaia; Svetlana A Limborska
Journal:  BMC Med Genet       Date:  2007-02-26       Impact factor: 2.103

Review 7.  The genetics of Parkinson's disease: progress and therapeutic implications.

Authors:  Andrew B Singleton; Matthew J Farrer; Vincenzo Bonifati
Journal:  Mov Disord       Date:  2013-01       Impact factor: 10.338

8.  Analysis of exon dosage using MLPA in South African Parkinson's disease patients.

Authors:  Rowena J Keyser; Debbie Lombard; Rene Veikondis; Jonathan Carr; Soraya Bardien
Journal:  Neurogenetics       Date:  2009-12-15       Impact factor: 2.660

9.  Clinical characteristics of Parkinson's disease among Jewish Ethnic groups in Israel.

Authors:  R Djaldetti; S Hassin-Baer; M J Farrer; C Vilariño-Güell; O A Ross; V Kolianov; S Yust-Katz; T A Treves; Y Barhum; M Hulihan; E Melamed
Journal:  J Neural Transm (Vienna)       Date:  2008-07-30       Impact factor: 3.575

10.  Analysis of PARK genes in a Korean cohort of early-onset Parkinson disease.

Authors:  Jung Mi Choi; Myoung Soo Woo; Hyeo-Il Ma; Suk Yun Kang; Young-Hee Sung; Seok Woo Yong; Sun Ju Chung; Joong-Seok Kim; Hae-won Shin; Chul Hyoung Lyoo; Phil Hyu Lee; Jong Sam Baik; Sang-Jin Kim; Mee Young Park; Young Ho Sohn; Jin-Ho Kim; Jae Woo Kim; Myung Sik Lee; Myoung Chong Lee; Dong-Hyun Kim; Yun Joong Kim
Journal:  Neurogenetics       Date:  2008-08-15       Impact factor: 2.660

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.